TITLE

Hormone replacement therapy for the primary prevention of chronic diseases: recommendation statement from the Canadian Task Force on Preventive Health Care

AUTHOR(S)
Wathen, C. Nadine; Feig, Denice S.; Feightner, John W.; Abramson, Beth L.; Cheung, Angela M.
PUB. DATE
May 2004
SOURCE
CMAJ: Canadian Medical Association Journal;5/11/2004, Vol. 170 Issue 10, p1535
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Provides information on hormone replacement therapy (HRT) for primary prevention of chronic diseases in the Canada. Recommendations of the Canadian Task Force on Preventive Health Care for HRT therapy in the country; Risk of breast cancer among women using HRT for the treatment of menopausal symptoms; Evidence on the positive and negative effects of HRT based on clinical trials conducted in the country.
ACCESSION #
12969252

 

Related Articles

  • The National Randomised Trial of Hormone Replacement Therapy in Women with a History of Early Stage Breast Cancer. Marsden, Jo // Journal of the British Menopause Society;2001, Vol. 7 Issue 2, p52 

    The article reports on the establishment of a national randomized trial of hormone replace therapy in women with a history of early stage breast cancer in Great Britain. 3,000 women will be recruited in the trial. The trial is funded by the Cancer Research Campaign and NHS Research and...

  • The national randomised trial of hormone replacement therapy in women with a history of early stage breast cancer: an update. Marsden, Jo; Sacks, Nigel // Journal of the British Menopause Society;2002, Vol. 8 Issue 4, p129 

    The article presents information on the national randomized trail of hormone replacement therapy (HRT) supported by the Cancer Research UK in women with a history of early stage breast cancer. The objective of the trail was to access the effects of HRT on symptom relief, quality of life,...

  • CANCER. PARK, ALICE // Time International (South Pacific Edition);2/14/2011, Vol. 177 Issue 6, p18 

    The article discusses a large British clinical trial of breast-cancer risk in menopausal women who use combination estrogen-and-progestin pills and estrogen-only pills for hormone therapy.

  • CANCER. PARK, ALICE // Time;2/14/2011, Vol. 177 Issue 6, p18 

    The article discusses a large British clinical trial of breast-cancer risk in menopausal women who use combination estrogen-and-progestin pills and estrogen-only pills for hormone therapy.

  • WHI: 11-year follow-up of breast cancer incidence and mortality.  // Reactions Weekly;11/6/2010, Issue 1326, p1 

    The article reports on the results from an 11-year follow-up of the Women's Health Initiative (WHI) trial aimed to determine the incidence and mortality of breast cancer in postmenopausal women who received combined hormone therapy.

  • antibiotics and breast cancer.  // Better Nutrition;May2004, Vol. 66 Issue 5, p20 

    Serious implication flow from a new liking antibiotic use with a 100 percent increased risk of breast cancer. For perspective, the increased risk of breast cancer from hormone replacement therapy found in the Womens' Health Initiative study— which unsettled doctors and patients...

  • Breast cancer: A brighter outlook: Why the rates are now falling.  // Consumer Reports on Health;Apr2007, Vol. 19 Issue 4, p7 

    The article focuses on two studies concerning the fall in breast cancer rates in the U.S. during 2003. According to a study conducted by the University of Texas M.D. Anderson Cancer Center in Houston, Texas, quitting the estrogen treatment for menopause symptoms is considered to be the prime...

  • RIVER of HOPE. Kanigel, Rachele // Natural Health;Oct2007, Vol. 37 Issue 9, p90 

    The article reports on the decline in the rates of breast cancer in the U.S. It reports that breast cancer rates are now at their lowest level since 1987. According to a study published in the "New England Journal of Medicine," in 2003 and 2004, 30,000 fewer women developed breast cancer than...

  • Breast cancer rates fall as women abandon HRT.  // Practice Nurse;2/27/2009, Vol. 37 Issue 4, p6 

    The article discusses research on the decline in breast cancer rates in women between the ages of 50 to 54 who terminated taking hormone replacement therapy (HRT) in Great Britain and U.S. It references a study by Max Parkin and colleagues, published in a 2009 issue of the journal "European...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics